Outer membrane barrier impairment by envC deletion reduces gut colonization of Crohn’s disease pathobiont Escherichia coli
Microbiology · 2024
DOI: 10.1099/mic.0.001509 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology, 2024. Verfasst von Tsuyoshi Miki und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, School of Pharmacy, Kitasato University, Tokyo, 108-8641, Japan. Hauptthemen laut MEDLINE: Escherichia coli, Crohn Disease, Endopeptidases, Escherichia coli Proteins. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Fuji Foundation for Protein Research.
Abstract (Originalsprache)
Adherent-invasive Escherichia coli (AIEC) has been implicated in the aetiology of Crohn’s disease (CD), a chronic inflammatory disorder of the gastrointestinal tract. The presence of Enterobacteriaceae , including AIEC, is heightened in the intestines of CD patients. Therefore, inhibiting AIEC colonization in the gastrointestinal tract could be a promising therapeutic intervention for CD. This study aims to assess the potential of EnvC as a novel therapeutic target, examining how disrupting EnvC activity through the deletion of the envC gene decreases AIEC gut colonization levels. EnvC serves as a catalyst for peptidoglycan (also called murein) amidases, facilitating bacterial cell division. An AIEC mutant lacking the envC gene exhibited impaired cell division. Furthermore, envC deletion led to a diminished outer membrane barrier, as seen in our finding that the envC mutant became susceptible to vancomycin. Finally, we found that the envC mutant is impaired in competitive gut colonization in a dysbiotic mouse model. The colonization defects might be attributable to reduced resistance to colonic bile acids, as evidenced by our finding that increased colonic levels of bile acids inhibited the colonization of the gastrointestinal tract by AIEC strains. The present findings suggest that targeting bacterial cell division through the inhibition of EnvC activity could represent a promising intervention for CD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, School of Pharmacy, Kitasato University, Tokyo, 108-8641, Japan.
Förderung
- Japan Society for the Promotion of Science
- Fuji Foundation for Protein Research
Zitieren
APA
Miki, T., Ito, M., Haneda, T., & Kim, Y. G. (2024). Outer membrane barrier impairment by envC deletion reduces gut colonization of Crohn’s disease pathobiont Escherichia coli. Microbiology. https://doi.org/10.1099/mic.0.001509
Vancouver
Miki T, Ito M, Haneda T, Kim YG. Outer membrane barrier impairment by envC deletion reduces gut colonization of Crohn’s disease pathobiont Escherichia coli. Microbiology. 2024. doi:10.1099/mic.0.001509
BibTeX
@article{Miki2024,
author = {Miki, Tsuyoshi and Ito, Masahiro and Haneda, Takeshi and Kim, Yun-Gi},
title = {Outer membrane barrier impairment by envC deletion reduces gut colonization of Crohn’s disease pathobiont Escherichia coli},
journal = {Microbiology},
year = {2024},
doi = {10.1099/mic.0.001509}
}
EUVIMED